News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
As an Asian American patient advocate, I am trying to raise awareness of care access challenges faced by immigrants groups – Tingting Zhang
Photo from Tingting Zhang / twitter
Aug 7, 2023, 07:09

As an Asian American patient advocate, I am trying to raise awareness of care access challenges faced by immigrants groups – Tingting Zhang

As an Asian American patient advocate, I am trying to raise awareness of care access challenges faced by immigrants groups for whom English or Spanish was not their official language at ASCO breakthrough 2023. We need to work with Asian countries to help us.As an Asian American patient advocate, I am trying to raise awareness of care access challenges faced by immigrants groups - Tingting Zhang

For the article: Click here
Source: Tingting Zhang / Twitter

ASCO breakthrough Asia cancer English OncoDaily Oncology Spanish Tingting Zhang
Special Coverage
Blog
Feb 11, 2025, 09:20
American Cancer Society Cancer Action Network - Oppose cuts to Medicaid and help save more lives from cancer
Blog
Feb 11, 2025, 09:12
Tigran Byuzandyan: Inspiring Connections at the 5th Oncology Congress
Blog
Feb 11, 2025, 09:07
Applications are open for the St. Elizabeth Service Internship Program - St. Elizabeth Healthcare
Blog
Feb 11, 2025, 09:02
Nelson Dusetti: The role of FKBP7 as a novel regulator of PSC activation and collagen remodeling in the PDAC
Blog
Feb 11, 2025, 08:58
Ulrika Årehed Kågström: Increasing knowledge about early signs of cancer among men
Blog
Feb 11, 2025, 08:58
Flavio Rocha: Honored to discuss cholangiocarcinoma at Johns Hopkins Medicine GI cancer course
Blog
Feb 11, 2025, 08:58
Rasha Aboelhassan: The best of ESMO 2024 Egypt
Blog
Feb 11, 2025, 08:57
Wafik S. El-Deiry: There are no trillion dollar endowments
Insight
Feb 11, 2025, 08:55
Bishal Gyawali: This is why we need randomized controlled trials
Blog
Feb 11, 2025, 08:51
Recap of key studies from GI25 - ASCO
Insight
Feb 11, 2025, 08:47
Jarushka Naidoo: Phase Ib Trial on Ivonescimab with Etoposide Plus Carboplatin in 1st line ES SCLC
Science
Feb 11, 2025, 08:43
Gustavo Viani: Should we rethink ADT omission in dose-escalated RT?